Literature DB >> 10951385

Synthetic nano-fibrillar extracellular matrices with predesigned macroporous architectures.

R Zhang1, P X Ma.   

Abstract

Scaffolding plays a pivotal role in tissue engineering. To mimic the architecture of a natural extracellular matrix component-collagen, nona-fibrous matrices have been created with synthetic biodegradable polymers in our laboratory using a phase-separation technique. To improve the cell seeding, distribution, mass transport, and new tissue organization, three-dimensional macroporous architectures are built in the nano-fibrous matrices. Water-soluble porogen materials are first fabricated into three-dimensional negative replicas of the desired macroporous architectures. Polymer solutions are then cast over the porogen assemblies in a mold, and are thermally phase-separated to form nano-fibrous matrices. The porogen materials are leached out with water to finally form the synthetic nano-fibrous extracellular matrices with predesigned macroporous architectures. In this way, synthetic polymer matrices are created with architectural features at several levels, including the anatomical shape of the matrix, macroporous elements (100 microm to millimeters), interfiber distance (microns), and the diameter of the fibers (50-500 nm). These scaffolding materials circumvent the concerns of pathogen transmission and immuno-rejection associated with natural collagen. With the flexibility in the design of chemical structure, molecular weight, architecture, degradation rate, and mechanical properties, these novel synthetic matrices may serve as superior scaffolding for tissue engineering. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10951385     DOI: 10.1002/1097-4636(200011)52:2<430::aid-jbm25>3.0.co;2-l

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  40 in total

Review 1.  Next generation of electrosprayed fibers for tissue regeneration.

Authors:  Jong Kyu Hong; Sundararajan V Madihally
Journal:  Tissue Eng Part B Rev       Date:  2011-02-20       Impact factor: 6.389

2.  Acrylic scaffolds with interconnected spherical pores and controlled hydrophilicity for tissue engineering.

Authors:  R Brígido Diego; M Pérez Olmedilla; A Serrano Aroca; J L Gómez Ribelles; M Monleón Pradas; G Gallego Ferrer; M Salmerón Sánchez
Journal:  J Mater Sci Mater Med       Date:  2005-08       Impact factor: 3.896

Review 3.  Biomimetic materials for tissue engineering.

Authors:  Peter X Ma
Journal:  Adv Drug Deliv Rev       Date:  2007-11-28       Impact factor: 15.470

4.  Novel anisotropic engineered cardiac tissues: studies of electrical propagation.

Authors:  Nenad Bursac; Yihua Loo; Kam Leong; Leslie Tung
Journal:  Biochem Biophys Res Commun       Date:  2007-08-02       Impact factor: 3.575

5.  Tissue Engineering with Nano-Fibrous Scaffolds.

Authors:  Laura A Smith; Xiaohua Liu; Peter X Ma
Journal:  Soft Matter       Date:  2008-01-01       Impact factor: 3.679

6.  Microablation of collagen-based substrates for soft tissue engineering.

Authors:  Vivek A Kumar; Adam W Martinez; Jeffrey M Caves; Nisarga Naik; Carolyn A Haller; Elliot L Chaikof
Journal:  Biomed Mater       Date:  2014-01-23       Impact factor: 3.715

Review 7.  Polymeric nanofibers in tissue engineering.

Authors:  Rebecca L Dahlin; F Kurtis Kasper; Antonios G Mikos
Journal:  Tissue Eng Part B Rev       Date:  2011-07-28       Impact factor: 6.389

8.  The fabrication of biomineralized fiber-aligned PLGA scaffolds and their effect on enhancing osteogenic differentiation of UCMSC cells.

Authors:  Wenqiang Li; Xiaohui Yang; Shanbao Feng; Shenyu Yang; Rong Zeng; Mei Tu
Journal:  J Mater Sci Mater Med       Date:  2018-07-19       Impact factor: 3.896

Review 9.  Biomaterials and stem cells for tissue engineering.

Authors:  Zhanpeng Zhang; Melanie J Gupte; Peter X Ma
Journal:  Expert Opin Biol Ther       Date:  2013-01-17       Impact factor: 4.388

10.  Nanostructured Biomaterials for Regeneration.

Authors:  Guobao Wei; Peter X Ma
Journal:  Adv Funct Mater       Date:  2008-11-24       Impact factor: 18.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.